Filter news stories by category:
-
Research news
20 August 2020
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
Research news
19 August 2020
UCLH Biomedical Research Centre supported Consultant Infectious Diseases Physician Professor Sir Alimuddin (Ali) Zumla has been awarded the 2020 Mahathir Science Award, the most prestigious international science award presented in recognition for the best scientific work in solving priority health problems in the tropics.
-
Research news
18 August 2020
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains which developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
-
Research news
07 August 2020
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).
-
UCLH news
03 August 2020
Follow brothers Chris and Xand van Tulleken as they experience COVID-19 as doctors and as a patient in a new BBC documentary filmed at UCLH.
-
Research news
31 July 2020
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
Research news
17 July 2020
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Research news
13 July 2020
Researchers have highlighted the importance of routinely screening healthcare staff for SARS-CoV-2 after finding a high proportion of frontline staff had the virus at the peak of the pandemic.
-
Research news
10 July 2020
Could dogs offer quick and effective diagnosis of COVID-19?
-
Research news
10 July 2020
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.